MARKET

NVAX

NVAX

Novavax Inc
NASDAQ
6.93
+0.09
+1.24%
Opening 14:44 07/14 EDT
OPEN
6.76
PREV CLOSE
6.84
HIGH
7.01
LOW
6.75
VOLUME
1.82M
TURNOVER
--
52 WEEK HIGH
17.81
52 WEEK LOW
5.01
MARKET CAP
1.12B
P/E (TTM)
2.597
1D
5D
1M
3M
1Y
5Y
1D
Is Trending Stock Novavax, Inc. (NVAX) a Buy Now?
NASDAQ · 15h ago
Weekly Report: what happened at NVAX last week (0707-0711)?
Weekly Report · 18h ago
Novavax Inc. Stock Falls 3.7%, Underperforms Competitors
Dow Jones · 3d ago
Despite Revenue Jump, Novavax Appears Immune To Long-Term Growth
Seeking Alpha · 3d ago
2 Beaten-Down Stocks That Haven't Hit Rock Bottom Yet
The Motley Fool · 3d ago
FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months
Benzinga · 4d ago
Novavax Inc. Stock Climbs 6.5%, Outperforms Competitors
Dow Jones · 6d ago
Moderna Stock Is Climbing. It Has Been a Tumultuous Few Days for Pharma.
Barron‘s · 6d ago
More
About NVAX
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.

Webull offers Novavax Inc stock information, including NASDAQ: NVAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVAX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVAX stock methods without spending real money on the virtual paper trading platform.